ReviewFrontiers in pharmacology2023

Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor-Ivacaftor.

Burkhard TümmlerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.